# Soo Kun Lim

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/soo-kun-lim/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,191 |
| Field | Dialysis and Renal Disease Management |
| h-index | 25 |
| i10-index | 57 |
| Last Known Institution | University Malaya Medical Centre |
| OpenAlex ID | https://openalex.org/A5037021026 |
| ORCID iD | 0000-0001-7589-5150 |
| Works | 188 |

## Researcher papers

- [Definition and diagnostic criteria of clinical obesity](https://scholariq.org/papers/definition-and-diagnostic-criteria-of-clinical-obesity/)
- [Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy](https://scholariq.org/papers/effect-of-oral-methylprednisolone-on-decline-in-kidney-function-or-kidney/)
- [Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial](https://scholariq.org/papers/effects-of-the-sglt2-inhibitor-dapagliflozin-on-proteinuria-in-non-diabetic/)
- [Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice](https://scholariq.org/papers/insights-from-credence-trial-indicate-an-acute-drop-in-estimated-glomerular/)
- [Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease](https://scholariq.org/papers/effect-of-sglt2-inhibitors-on-stroke-and-atrial-fibrillation-in-diabetic-kidney/)
- [Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial](https://scholariq.org/papers/impact-of-primary-kidney-disease-on-the-effects-of-empagliflozin-in-patients/)
- [Recommendations by the Asian Pacific society of nephrology (<scp>APSN</scp>) on the appropriate use of <scp>HIF‐PH</scp> inhibitors](https://scholariq.org/papers/recommendations-by-the-asian-pacific-society-of-nephrology-scp-apsn-scp-on-the/)
- [Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial](https://scholariq.org/papers/effects-of-empagliflozin-on-progression-of-chronic-kidney-disease-a-prespecified/)
- [A Review of Commercial Developments and Recent Laboratory Research of Dialyzers and Membranes for Hemodialysis Application](https://scholariq.org/papers/a-review-of-commercial-developments-and-recent-laboratory-research-of-dialyzers/)
- [Evidence for the detrimental role of proteolysis during liver preservation in humans](https://scholariq.org/papers/evidence-for-the-detrimental-role-of-proteolysis-during-liver-preservation-in/)
- [Kidney and Survival Benefits of Semaglutide in Diabetes With Chronic Kidney Disease](https://scholariq.org/papers/kidney-and-survival-benefits-of-semaglutide-in-diabetes-with-chronic-kidney/)

## Researcher topics

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Organ Donation and Transplantation](https://scholariq.org/topics/organ-donation-and-transplantation/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Researcher university

- [University Malaya Medical Centre](https://scholariq.org/institutions/university-malaya-medical-centre/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.